FDA’s Electronic Premarket Submissions Pilot Program

by | Oct 26, 2020 | FDA, Medical Devices, Quality, Regulatory

The US FDA’s Center for Devices and Radiological Health (CDRH) announced a new pilot program that will allow the industry to submit premarket submissions electronically during the COVID-19 health emergency.1

The Electronic Delivery of Premarket Submissions Pilot Program’s objective is to test CDRH’s capabilities to receive pre-market submissions using BOX, which is a cloud-based sharing service. CDRH began accepting participants for this pilot on October 6th,2020 and the program is intended to last 90 days during the COVID-19 pandemic.1

The following is the eligibility criteria apply to enter the pilot program:1

  • Companies who intend to submit an e-copy of a premarket submission within 2 weeks of acceptance into the pilot program.
  • Can download and work with Box to upload files.
  • Follow the required procedures for participants

CDRH has the right to withdraw the application of the participant if it finds that a participant is ineligible.

If you would like to participate in the program, you can submit a statement of interest to  CDRH-Premarket-Submission-eDelivery-Support@fda.hhs.gov and include your statement of agreement to comply with the eligibility criteria listed above, a description of the premarket submission you intend on submitting within 2 weeks, and information on the size of your organization such as the number of employees and your revenue per year.1

CDRH will select up to 25 applicants that will include a broad spectrum of applicant types such as consultants that represent applicants. Enrollment will be ongoing throughout the pilot program.1

EMMA International will be happy to represent your application if you wish to participate in this pilot program. Call us today at +1 248-987-4497 or email us at info@emmainternatiional.com to learn more about how we can help.

1FDA (Oct 2020) Electronic Delivery of Premarket Submissions Pilot retrieved on 10/22/2020 from https://www.fda.gov/medical-devices/how-study-and-market-your-device/electronic-delivery-premarket-submissions-pilot


Nikita Angane

Nikita Angane

Solutions Delivery Specialist - Ms. Angane is a Bioengineering graduate with experience in medical device commercialization, product development, quality system compliance and regulatory affairs. Her portfolio includes working on medical devices, combination products, and pharmaceuticals. As a Solutions Delivery Specialist at EMMA International, she offers her expertise to help our clients achieve an effective and sustainable quality system, and develop regulatory strategies for market access and compliance of new products in the US and international markets. Ms. Angane earned a Bachelor of Engineering in Biomedical Engineering from the University of Mumbai, India and an M.S. in Bioengineering from University of Illinois at Chicago.

More Resources

FDA Adverse Event Reporting 

FDA Adverse Event Reporting 

When reporting an Adverse Event to the Food and Drug Administration (FDA) the best method is to utilize the FDA Adverse Event Reporting System (FAERS). FAERS is a database that contains adverse event reports, product quality complaints that led to an adverse event, and medication error reports1. All FAERS reports are easily accessible to the public. 
De Novo Classification

De Novo Classification

A device can be registered for the De Novo pathway if there is evidence of the safety and effectiveness of the device and there is not a previously legally marketed predicate device1. When determining if your device can go through the De Novo process there are two pathways available to determine the device classification.
Abbreviated 510k submission

Abbreviated 510k submission

There are three types of 510K, Premarket Notifications, which can be submitted to the Food and Drug Administration (FDA) traditional, abbreviated, and special. Abbreviated and Special 510K submissions can be utilized when the submissions meet the certain factors presented by the FDA. When submitting an abbreviated 510K the submission must include the elements that are identified in 21CFR 807.87 for the information required in a premarket notification submission.

Ready to learn more about working with us?

Pin It on Pinterest

Share This